Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa
NCT06685835Phase 2Terminated
- Sponsor
- Insmed Incorporated
- Start
- Dec 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of brensocatib in hidradenitis suppurativa (HS), sponsored by Insmed Incorporated. Started Dec 2024; status: terminated.
02
Drugs
brensocatib
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT06685835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06685835.